TP53 and cancer: The inhibition of these pathways does not wholly depend on MTH1 suppression-induced DNA strand breaks (Figure 3D), which is lower in extent than what we have previously observed in either MTH1-suppressed fibroblasts [16] or established RAS-driven p53-competent cancer cells [5].